The Applied Biologics team is dedicated to success. The executive team, medical advisory board, scientific advisory board, researchers, product development team, manufacturing technicians, distribution team, sales representatives, support team, reimbursement department and administrative staff are professionals and leaders in their fields. Together, we continue to strive for excellence and being a leader in delivering biological solutions.
Applied Biologics™ is a worldwide preeminent source of regenerative medicine technology, clinical research, education and training for the constantly evolving healthcare industry.
Through innovation and development of new technologies with a proven track record of success, Applied Biologics is committed to being a leader in regenerative medicine products.
Abstract, Articles and Posters
-
Abstract
Diabetic foot ulcers (DFUs) represent a chronic and debilitating complication of diabetes, contributing substantially to patient morbidity, mortality, and economic burden. Despite advances in clinical management, outcomes with the current standard of care (SOC) remain suboptimal, with many ulcers failing to achieve complete closure. These limitations reinforce the need for innovative, cost-effective solutions that promote wound closure.
-
Article
Background: Diabetic foot ulcers (DFUs) represent a chronic and debilitating complication of diabetes, contributing substantially to patient morbidity, mortality, and economic burden. Despite advances in clinical management, outcomes with the current standard of care (SOC) remain suboptimal, with many ulcers failing to achieve complete closure. These limitations reinforce the need for innovative, cost-effective solutions that promote wound closure.
Podium Presenation
Secure Your Spot at TRES Spring in 2026
Be the First to Register for TRES Spring 2026
Join clinical leaders and industry innovators at the next evolution in evidence-based wound care.
📅 February 27–28, 2026
🌐 Dedicated website goes live October 2026.
